Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel
NASDAQ:BMRA

Biomerica 10/21/2026 Earnings Report

Biomerica logo
$2.46 -0.15 (-5.75%)
Closing price 04:00 PM Eastern
Extended Trading
$2.45 -0.01 (-0.24%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Biomerica EPS Results

Actual EPS
N/A
Consensus EPS
-$1.20
Beat/Miss
N/A
One Year Ago EPS
N/A

Biomerica Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.63 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Biomerica Announcement Details

Quarter
Date
10/21/2026
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Biomerica Earnings Headlines

Biomerica (NASDAQ:BMRA) Stock Price Crosses Above 50-Day Moving Average - Here's Why
September 22 at 4:00 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31038729
Biomerica Posts Narrower Q4 Loss On Higher Sales; Stock Down
September 2, 2026  |  rttnews.comhttps://www.rttnews.com/3687774/biomerica-posts-narrower-q4-loss-on-higher-sales-stock-down.aspx
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
September 24 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization
September 1, 2026  |  quiverquant.comQ
Biomerica Reports Fiscal 2026 Year-End Financial Results
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354133/0/en/biomerica-reports-fiscal-2026-year-end-financial-results.html
Biomerica Inc.
August 31, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/bmra-biomerica-inc/vitals
See More Biomerica Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biomerica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biomerica and other key companies, straight to your email.

About Biomerica

Biomerica (NASDAQ:BMRA) is a medical technology company that develops, manufactures and commercializes diagnostic and therapeutic products, with a primary focus on gastrointestinal disorders and other medical conditions. The company is headquartered in Irvine, California, and serves healthcare providers and patients in the United States and selected international markets through direct sales and distribution relationships.

Biomerica’s principal product is inFoods IBS, a diagnostic-guided dietary management program for irritable bowel syndrome. The program combines a blood-based test intended to identify foods that may contribute to an individual’s symptoms with a personalized dietary plan designed to help patients manage those symptoms. Biomerica has also developed and marketed diagnostic products addressing gastrointestinal and infectious-disease applications.

The company has historically focused on combining diagnostic testing with individualized treatment or dietary-management approaches. Zackary Irani serves as Biomerica’s president and chief executive officer and has been associated with the company’s leadership for several years.

View Biomerica Profile
Earnings Tools